Yasuhiro Tsuda
Overview
Explore the profile of Yasuhiro Tsuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuda Y, Suzuki K, Minamiguchi Y, Yamanaka M, Doi T, Tomari Y, et al.
Medicine (Baltimore)
. 2024 Jul;
103(27):e38734.
PMID: 38968528
Cancer is a common health problem worldwide. Early cancer education for adolescents and young adults (AYAs) is important for the prevention or early detection of cancer. In this questionnaire-based cross-sectional...
2.
Tsuchitani T, Tomaru A, Aoki Y, Ishiguro N, Tsuda Y, Sugiyama Y
CPT Pharmacometrics Syst Pharmacol
. 2024 May;
13(7):1224-1237.
PMID: 38745377
Telmisartan, a selective inhibitor of angiotensin II receptor type 1 (AT1), demonstrates nonlinear pharmacokinetics (PK) when orally administered in ascending doses to healthy volunteers, but the underlying mechanisms remain unclear....
3.
Suzuki K, Hayashi N, Yamanaka M, Minamiguchi Y, Yamauchi E, Fukawa A, et al.
Arch Public Health
. 2024 May;
82(1):71.
PMID: 38745251
Background: The early detection and prevention of many cancers is possible. Therefore, public awareness about cancer risk factors and warning signs must be increased to ensure early diagnosis. Although Japan...
4.
Ito K, Naoi M, Nishiyama K, Kudo T, Tsuda Y, MacLean C, et al.
Drug Metab Pharmacokinet
. 2023 Feb;
49:100487.
PMID: 36724603
P-glycoprotein (P-gp) expression in lymphocytes is variable and 2-fold higher in rheumatoid arthritis (RA) patients with treatment resistance than in healthy subjects. To date the information on P-gp-mediated drug interaction...
5.
Sato T, Tanaka S, Akazawa C, Tsuda Y, Teraguchi S, Kai S, et al.
Transplant Proc
. 2022 Sep;
54(8):2337-2343.
PMID: 36180255
Background: Dyspnea is an important problem that might affect the clinical course after lung transplantation; however, the prevalence, risk factors, and relevant outcomes of dyspnea in the intensive care unit...
6.
Suzuki K, Yamanaka M, Minamiguchi Y, Hayashi N, Yamauchi E, Fukawa A, et al.
J Adolesc Young Adult Oncol
. 2022 Feb;
12(1):9-33.
PMID: 35180351
The purpose of this review was to establish what cancer education programs have been carried out aimed at adolescents and young adults (AYAs) and what outcomes they achieved. The databases...
7.
Tsuda Y, Grimaldi C, Huang F, Benediktus E, Yagi N, Padula S, et al.
Br J Clin Pharmacol
. 2020 Oct;
87(4):2000-2013.
PMID: 33047859
Aims: To evaluate the safety, pharmacokinetics and pharmacodynamics of BI 655064 in healthy Chinese and Japanese subjects after administration of single doses of 80-240 mg and multiple dosing of 240...
8.
Tsuda Y, Ugai H, Wunderlich G, Shin J
Clin Ther
. 2019 Apr;
41(5):961-971.
PMID: 31005336
Purpose: This study's primary goal was to evaluate the safety profile, tolerability, pharmacokinetics, and dose proportionality of BI 425809, a potent and selective inhibitor of glycine transporter 1, in healthy...
9.
Enomoto M, Nishiguchi S, Tamori A, Kozuka R, Fujii H, Uchida-Kobayashi S, et al.
Hepatol Res
. 2018 Jan;
48(6):459-468.
PMID: 29314465
Aim: The optimal combination of two currently available agents with different mechanisms of action, a nucleos(t)ide analog and pegylated interferon-α (PegIFNα), must be determined to improve treatment of chronic hepatitis...
10.
Nishikawa T, Asai A, Okamoto N, Yasuoka H, Nakamura K, Yokohama K, et al.
J Clin Biochem Nutr
. 2017 Dec;
61(3):222-227.
PMID: 29203965
Transarterial chemoembolization and hepatic arterial infusion chemotherapy are recommended for the treatment in patients with intermediate stage of hepatocellular carcinoma. Impaired liver function was sometime observed in patients with hepatocellular...